Oxford Biomedica Solutions
Jon Duffty has a diverse work experience in facilities operations and management. Jon currently holds the position of Associate Director, Facilities Operations at Oxford Biomedica Solutions. Prior to this, they worked as a Senior Manager of Site and Facilities at the same company. Before joining Oxford Biomedica Solutions, Jon was a Senior Manager of Facilities and a Manager of GMP Facilities at Homology Medicines, Inc. Jon also served as a Facilities Team Leader at Cytiva. Jon's earlier roles include Maintenance Group Lead Utilities and Maintenance Tech Senior Lead at Sanofi, as well as a Maintenance Technician at Pfizer. Overall, Jon has over 15 years of experience in the field of facilities management and maintenance.
Jon Duffty attended Whittier Vocational Technical High School from 1999 to 2003. During this time, they obtained their high school diploma with a focus on electrical studies.
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.